Neumentum
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
350 Springfield Ave Ste 200, Summit, New...Phone Number
(917) 865-0232Website
www.neumentum.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Neumentum
Neumentum, Inc. is a pharmaceutical company focused on developing non-opioid analgesics and neurology specialty products. The company aims to improve pain management by providing effective and safe alternatives to opioids, addressing issues such as abuse and side effects associated with traditional pain treatments. Neumentum has a pipeline of four novel non-opioid products in development for both acute and chronic pain. Their target clients include patients seeking safer pain management options in the U.S. and globally.Explore more
Neumentum Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neumentum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Neumentum, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Neumentum recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Neumentum
Click to see if Neumentum had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Neumentum has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Neumentum has recently received funding, and reach out quickly before it becomes old news!
Check out if Neumentum is spiking on competitors!
Product Launch: Get notified when Neumentum launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Neumentum
Compare insights from companies similar to Neumentum, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neumentum is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neumentum is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neumentum.
Neumentum Tech Stack
A closer look at the technologies used by Neumentum
See more technologies
Neumentum News & Media
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre
All 16 healthy normal volunteers (HNVs) were dosed and no serious adverse event was reported The NTM-001 Phase I clinical study is expected to be completed by the end of 2022 SHANGHAI, July 26, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the completion of dosing for all...Neumentum and NEMA Research Inc. Named to Short-List of Citeline Awards for 2021
Nominated for Most Successful Early-Phase ResearchNeumentum to Participate in the UBS Biotechnology Private Company Symposium
MORRISTOWN, N.J., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer and co-founder of Neumentum, and Dr. Joseph Pergolizzi, Executive Chairman and co-founder of Neumentum, will provide a brief corporate update at the UBS Virtual Biotechnology Private Company Symposium on Wednesday, September 22, 2021 at 4:00PM ET. Management will also host inNeumentum to Participate in Upcoming January Virtual Investor Conferences
MORRISTOWN, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer at Neumentum, will present at two upcoming investor conferences in January.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neumentum
Sign Up For FreeTo access detailed company insights
Neumentum, Inc. is a pharmaceutical company focused on developing non-opioid analgesics and neurology specialty products. The company aims to improve pain management by providing effective and safe alternatives to opioids, addressing issues such as abuse and side effects associated with traditional pain treatments. Neumentum has a pipeline of four... Read More
